156 related articles for article (PubMed ID: 35666530)
1. Redesign of a rapid, low-cost HPV typing assay to support risk-based cervical screening and management.
Desai KT; Adepiti CA; Schiffman M; Egemen D; Gage JC; Wentzensen N; de Sanjose S; Burk RD; Ajenifuja KO
Int J Cancer; 2022 Oct; 151(7):1142-1149. PubMed ID: 35666530
[TBL] [Abstract][Full Text] [Related]
2. A rapid HPV typing assay to support global cervical cancer screening and risk-based management: A cross-sectional study.
Inturrisi F; de Sanjosé S; Desai KT; Dagnall C; Egemen D; Befano B; Rodriguez AC; Jeronimo JA; Zuna RE; Hoffman A; Farhat Nozzari S; Walker JL; Perkins RB; Wentzensen N; Palefsky JM; Schiffman M
Int J Cancer; 2024 Jan; 154(2):241-250. PubMed ID: 37772799
[TBL] [Abstract][Full Text] [Related]
3. Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
Demarco M; Carter-Pokras O; Hyun N; Castle PE; He X; Dallal CM; Chen J; Gage JC; Befano B; Fetterman B; Lorey T; Poitras N; Raine-Bennett TR; Wentzensen N; Schiffman M
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29491018
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
5. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi.
Mungo C; Guliam A; Chinula L; Inturrisi F; Msowoya L; Mkochi T; Jawadu S; de Sanjosé S; Schiffman M; Tang JH; Smith JS
medRxiv; 2024 Feb; ():. PubMed ID: 38617305
[TBL] [Abstract][Full Text] [Related]
7. AmpFire HPV and ScreenFire RS HPV validation trial.
Hou J; Belinson JL; Du H; Li C; Zhang W; Zhang L; Zhang Y; Qu X; Wu R
Am J Clin Pathol; 2024 Feb; ():. PubMed ID: 38365314
[TBL] [Abstract][Full Text] [Related]
8. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
[No Abstract] [Full Text] [Related]
9. [High-risk HPV genotyping PCR testing as a means of cervical cancer and precancerous lesions early screening].
Ma L; Cong X; Bian M; Shi M; Wang X; Liu J; Liu H
Zhonghua Fu Chan Ke Za Zhi; 2015 Apr; 50(4):246-52. PubMed ID: 26080934
[TBL] [Abstract][Full Text] [Related]
10. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
11. Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening.
Ejegod DM; Lagheden C; Bhatia R; Pedersen H; Boada EA; Sundström K; Cortés J; Josë FXB; Cuschieri K; Dillner J; Bonde J
BMC Cancer; 2020 May; 20(1):396. PubMed ID: 32375689
[TBL] [Abstract][Full Text] [Related]
12. Design of the HPV-Automated Visual Evaluation (PAVE) Study: Validating a Novel Cervical Screening Strategy.
de Sanjosé S; Perkins RB; Campos NG; Inturrisi F; Egemen D; Befano B; Rodriguez AC; Jerónimo J; Cheung LC; Desai K; Han P; Novetsky AP; Ukwuani A; Marcus J; Ahmed SR; Wentzensen N; Kalpathy-Cramer J; Schiffman M;
medRxiv; 2023 Oct; ():. PubMed ID: 37693492
[TBL] [Abstract][Full Text] [Related]
13. Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination.
Song F; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
BMC Cancer; 2022 Jan; 22(1):42. PubMed ID: 34991494
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two PCR-based human papillomavirus genotyping methods.
Castle PE; Porras C; Quint WG; Rodriguez AC; Schiffman M; Gravitt PE; González P; Katki HA; Silva S; Freer E; Van Doorn LJ; Jiménez S; Herrero R; Hildesheim A;
J Clin Microbiol; 2008 Oct; 46(10):3437-45. PubMed ID: 18716224
[TBL] [Abstract][Full Text] [Related]
15. [Detection and typing of human papilloma virus by polymerase chain reaction and hybridization assay in cervical samples with cytological abnormalities].
Ergünay K; Misirlioğlu M; Firat P; Tuncer ZS; Tuncer S; Yildiz I; Ustaçelebi S
Mikrobiyol Bul; 2008 Apr; 42(2):273-82. PubMed ID: 18697425
[TBL] [Abstract][Full Text] [Related]
16. Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States.
Bukowski A; Hoyo C; Hudgens MG; Brewster WR; Valea F; Bentley RC; Vidal AC; Maguire RL; Schmitt JW; Murphy SK; North KE; Smith JS
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1564-1571. PubMed ID: 35654413
[TBL] [Abstract][Full Text] [Related]
17. Alinity m HR HPV Assay Fulfills Criteria for Human Papillomavirus Test Requirements in Cervical Cancer Screening Settings.
Oštrbenk Valenčak A; Šterbenc A; Seme K; Poljak M
J Clin Microbiol; 2019 Dec; 58(1):. PubMed ID: 31666369
[TBL] [Abstract][Full Text] [Related]
18. Use of Multiplex Polymerase Chain Reaction for Detection of High-Risk Human Papillomavirus Genotypes in Women Attending Routine Cervical Cancer Screening in Harare.
Marembo T; Dube Mandishora R; Borok M
Intervirology; 2019; 62(2):90-95. PubMed ID: 31412350
[TBL] [Abstract][Full Text] [Related]
19. Isothermal Method of a Recombinase Polymerase Amplification Assay for the Detection of Most Common High-Risk Human Papillomavirus Type 16 and Type 18 DNA.
Ma B; Fang J; Wang Y; He H; Dai M; Lin W; Su W; Zhang M
Clin Lab; 2017 Jan; 63(1):27-38. PubMed ID: 28164495
[TBL] [Abstract][Full Text] [Related]
20. Head-to-Head Comparison of DH3 HPV Test and HC2 Assay for Detection of High-Risk HPV Infection in Residual Cytology Samples from Cervical Cancer Screening Setting: Baseline and 3-Year Longitudinal Data.
Fu Y; Li X; Li Y; Lu W; Xie X; Wang X
Microbiol Spectr; 2022 Feb; 10(1):e0157021. PubMed ID: 35171029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
